Your browser doesn't support javascript.
loading
Symptomatic benefit of momelotinib in patients with myelofibrosis: Results from the SIMPLIFY phase III studies.
Mesa, Ruben A; Hudgens, Stacie; Floden, Lysbeth; Harrison, Claire N; Palmer, Jeanne; Gupta, Vikas; McLornan, Donal P; McMullin, Mary F; Kiladjian, Jean-Jaques; Foltz, Lynda; Platzbecker, Uwe; Fox, M Laura; Mead, Adam J; Ross, David M; Oh, Stephen T; Perkins, Andrew; Leahy, Michael F; Deheshi, Samineh; Donahue, Rafe; Klencke, Barbara J; Verstovsek, Srdan.
Afiliação
  • Mesa RA; Atrium Health Wake Forest Baptist Comprehensive Cancer Center, Wake Forest University School of Medicine, Winston Salem, North Carolina, USA.
  • Hudgens S; Clinical Outcomes Solutions, Tucson, Arizona, USA.
  • Floden L; Clinical Outcomes Solutions, Tucson, Arizona, USA.
  • Harrison CN; Guy's and St. Thomas' NHS Foundation Trust, London, UK.
  • Palmer J; Mayo Clinic, Phoenix, Arizona, USA.
  • Gupta V; University Health Network, University of Toronto, Toronto, Ontario, Canada.
  • McLornan DP; Guy's and St. Thomas' NHS Foundation Trust, London, UK.
  • McMullin MF; Queens University, Belfast City Hospital Trust, Belfast, UK.
  • Kiladjian JJ; Hôpital Saint-Louis, Université de Paris, Paris, France.
  • Foltz L; St Paul's Hospital, University of British Columbia, Vancouver, British Columbia, Canada.
  • Platzbecker U; Leipzig University Hospital, Leipzig, Germany.
  • Fox ML; Hematology Department, Hospital Universitario Vall d'Hebron, Experimental Hematology, Vall d'Hebron Institute of Oncology (VHIO), Hospital Universitario Vall d'Hebron, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.
  • Mead AJ; MRC Weatherall Institute of Molecular Medicine, Oxford, UK.
  • Ross DM; Flinders Medical Centre and University, Adelaide, South Australia, Australia.
  • Oh ST; Washington University School of Medicine, St. Louis, Missouri, USA.
  • Perkins A; Alfred Hospital, Monash University, Melbourne, Victoria, Australia.
  • Leahy MF; University of Western Australia, Perth, Western Australia, Australia.
  • Deheshi S; Sierra Oncology, Plymouth, Michigan, USA.
  • Donahue R; Sierra Oncology, Plymouth, Michigan, USA.
  • Klencke BJ; Sierra Oncology, Plymouth, Michigan, USA.
  • Verstovsek S; MD Anderson Cancer Center, Houston, Texas, USA.
Cancer Med ; 12(9): 10612-10624, 2023 05.
Article em En | MEDLINE | ID: mdl-37021939
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Mielofibrose Primária / Inibidores de Janus Quinases Tipo de estudo: Diagnostic_studies / Prognostic_studies Aspecto: Patient_preference Limite: Humans Idioma: En Revista: Cancer Med Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Mielofibrose Primária / Inibidores de Janus Quinases Tipo de estudo: Diagnostic_studies / Prognostic_studies Aspecto: Patient_preference Limite: Humans Idioma: En Revista: Cancer Med Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos